Market Overview
The Global Microcatheters Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Microcatheters are thin-walled micro-diameter tubes mainly used for minimally invasive delivery device procedures. They are essential tools for performing surgeries in cardiology. They are used in stent placement, angioplasty, embolization, and other procedures. The treatments require catheterization that has to be very precise hence, microcatheters are used which helps in reaching narrow locations in the body.
These are used in minimally invasive procedures which has increased these days due to the ease with which it can be performed. It has become the standard of care in many countries due to its success rate. Aesthetic and plastic surgeons performing minimally invasive surgeries have increased due to the rising demand among people.
Market Scope
| Metrics | Details |
| CAGR | YY% |
| Market Size | 2021-2030 |
| Market Estimation Forecast Period | 2023-2030 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Type, Design, Application, End User and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | Asia-Pacific |
| Fastest Growing Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Rising FDA approvals for microcatheters
FDA approval has been on the rise due to the increase in the demand for microcatheters for several embolic procedures and Percutaneous Coronary Intervention (PCI). In recent studies, microcatheters have shown good support in treating calcified lesions in otherwise difficult procedures. Some microcatheters are also used in several neuro-interventional procedures because of the presence of the smallest lumen. Due to the use and demand in the market, FDA approvals were on the rise.
For instance, in December 2023, Transit Scientific received US Food and Drug Administration clearance for its microcatheter design for precise delivery of a broad range of embolic agents.
Furthermore, in May 2023, Reflow Medical, Inc. received FDA clearance for its CoraCatheters line of microcatheters that are designed to access and cross complex and challenging lesions in percutaneous coronary intervention (PCI).
In August 2023, Wallaby Medical's pNOVUS 17 Microcatheter was approved in China, USA, and Japan.
Risks associated with microcatheters
The risks associated with microcatheters are aneurysm wall perforation, non-target embolization, and other complications. There are many limitations associated with the design and use of microcatheters which include flow rate, trackability, and compatibility.
Advancements are necessary to improve all these limitations that can improve treatment delivery. Not all microcatheters are used in every procedure, as the procedures require very specific measurements and designs for better treatment outcomes.
Segment Analysis
The global microcatheters are segmented based on type, design, application, end-user and region.
The diagnostic microcatheters segment accounted for approximately 45.7% of the market share
Diagnostic microcatheters are used for the imaging of abnormalities such as tumors and vascular aneurysm embolization. These procedures are crucial for the detection of diseases like cancer and blockages in the body. Market developments by key companies drive the microcatheters market.
In October 2023, Merit Medical Systems launched the Maestro Microcatheter Line expansion which also includes new longer lengths for radial embolization procedures that are used for diagnostic and therapeutic procedures.
Furthermore, in March 2022, Guerbet expanded its portfolio by doubling its line of microcatheters and launching a new line of guidewires for interventional imaging and embolization.
Geographical Analysis
North America accounted for approximately 41.2% of the market share in 2022
North America is expected to hold the largest segment in the market due to the increase in minimally invasive procedures in this region. Minimally invasive procedures increased drastically due to the increase in the usage of sophisticated equipment in surgical procedures. It involves less pain and fewer complications compared to general surgery. The hospital stay time is also very less due to the minimal intervention with the body. An increase in minimally invasive procedures drive the microcatheters market in the forthcoming period.
According to the World Journal of Emergency Surgery, 2022, the USA reported a higher proportion of minimally invasive surgery in emergency general surgery (69.4%). In America, the cosmetic procedures in males increased by 27% and the total cosmetic minimally-invasive procedures in males increased by 72% by 2019.
Furthermore, in February 2023, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), 2023, 82% of the total number of procedures performed in 2022 were minimally invasive; the remaining 18% were surgical. This data reveals that the number of minimally invasive surgeries has increased in the US.
COVID-19 Impact Analysis
COVID-19 moderately impacted the microcatheter market due to the stoppage of unimportant surgical procedures due to the fear of contracting the disease. The world was under lockdown and so were the hospitals. Hence, the focus was shifted entirely towards the diagnosis and treatment of COVID-19. Due to the increase in the COVID-19 cases during the midst of the pandemic, many procedures were postponed which decreased the microcatheter usage that hindered the market.
Competitive Landscape
The major global players in the microcatheters market include Boston Scientific Corporation, Cardinal Health, Inc., Abbott Laboratories, Terumo Corporation, Medtronic plc, Stryker Corporation, Teleflex Incorporated, Cook Group Incorporated, Integer Holdings Corporation, Biotronik among others.
Key Developments
- In July 2020, ACIST Medical Systems, Inc. launched the ACIST Navvus II Rapid Exchange FFR MicroCatheter, the second-generation microcatheter for use with its ACIST RXi Rapid Exchange FFR System.
Why Purchase the Report?
- To visualize the global microcatheters market segmentation based on type, design, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of microcatheters market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global microcatheters market report would provide approximately 65 tables, 72 figures, and 195 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
